0000000000079934

AUTHOR

Sebastiano Cosentino

0000-0002-9404-843x

showing 7 related works from this author

The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma

2016

// Alessandra Romano 1 , Nunziatina Laura Parrinello 1 , Calogero Vetro 1 , Daniele Tibullo 1 , Cesarina Giallongo 1 , Piera La Cava 1 , Annalisa Chiarenza 1 , Giovanna Motta 1 , Anastasia L. Caruso 1 , Loredana Villari 2 , Claudio Tripodo 3 , Sebastiano Cosentino 4 , Massimo Ippolito 4 , Ugo Consoli 5 , Andrea Gallamini 6 , Stefano Pileri 7 , Francesco Di Raimondo 1 1 Division of Hematology, AOU “Policlinico - Vittorio Emanuele”, University of Catania, Catania, Italy 2 Division of Pathology, AOU “Policlinico - Vittorio Emanuele”, Catania, Italy 3 Tumor Immunology Unit, Department of Health Science, University of Palermo, Palermo, Italy 4 Nuclear Medicine Center, Azienda Ospedaliera Cannizz…

0301 basic medicineMaleCancer ResearchMyeloidNeutrophilsmedicine.medical_treatmentArginase-1Treatment outcomeKaplan-Meier EstimateGastroenterology0302 clinical medicineHematologyHealthy subjectsImmunosuppressionHematologyMiddle AgedPrognosisHodgkin DiseaseTreatment Outcomemedicine.anatomical_structureOncology030220 oncology & carcinogenesisFemaleArginase-1; Hodgkin Lymphoma; PET-2Tumor immunologyResearch PaperAdultmedicine.medical_specialtyPrognostic variableAdolescentAntineoplastic AgentsPET-2Sensitivity and SpecificityDisease-Free SurvivalYoung Adult03 medical and health sciencesInternal medicineBiomarkers TumormedicineHumansProgression-free survivalAgedArginasebusiness.industryMyeloid-Derived Suppressor Cells030104 developmental biologyPotential biomarkersImmunologyHodgkin lymphomabusinessHodgkin lymphoma030215 immunologyOncotarget
researchProduct

Primary Extracranial Meningiomas of the Head and Neck

2021

Meningiomas represent the most common benign histological tumor of the central nervous system. Usually, meningiomas are intracranial, showing a typical dural tail sign on brain MRI with Gadolinium, but occasionally they can infiltrate the skull or be sited extracranially. We present a systematic review of the literature on extracranial meningiomas of the head and neck, along with an emblematic case of primary extracranial meningioma (PEM), which provides further insights into PEM management. A literature search according to the PRISMA statement was conducted from 1979 to June 2021 using PubMed, Web of Science, Google Scholar, and Scopus databases, searching for relevant Mesh terms (primary …

medicine.medical_specialtySciencemedicine.medical_treatmentextracranial meningiomaPsammomatous MeningiomaMalignancyGeneral Biochemistry Genetics and Molecular BiologyMeningiomaplastic surgeryMedicineGrading (tumors)Ecology Evolution Behavior and SystematicsCraniotomySettore MED/27 - Neurochirurgiabusiness.industryBenignityQPaleontologycraniotomyscalp flap reconstructionmedicine.diseasePlastic surgerySkullmedicine.anatomical_structureSpace and Planetary ScienceRadiologySystematic ReviewbusinessLife
researchProduct

Robustness of PET Radiomics Features: Impact of Co-Registration with MRI

2021

Radiomics holds great promise in the field of cancer management. However, the clinical application of radiomics has been hampered by uncertainty about the robustness of the features extracted from the images. Previous studies have reported that radiomics features are sensitive to changes in voxel size resampling and interpolation, image perturbation, or slice thickness. This study aims to observe the variability of positron emission tomography (PET) radiomics features under the impact of co-registration with magnetic resonance imaging (MRI) using the difference percentage coefficient, and the Spearman’s correlation coefficient for three groups of images: (i) original PET, (ii) PET after co-…

TechnologyTomografía de emisión de positronesNeoplasias encefálicasCorrelation coefficientImagen por resonancia magnética:Phenomena and Processes::Mathematical Concepts::Probability::Uncertainty [Medical Subject Headings]QH301-705.5Computer scienceQC1-999:Diseases::Neoplasms::Neoplasms by Site::Nervous System Neoplasms::Central Nervous System Neoplasms::Brain Neoplasms [Medical Subject Headings]:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Imaging::Magnetic Resonance Imaging [Medical Subject Headings]Co registrationFluid-attenuated inversion recovery:Organisms::Eukaryota::Animals::Chordata::Vertebrates::Mammals::Primates::Haplorhini::Catarrhini::Hominidae::Humans [Medical Subject Headings]Magnetic resonance imagingRadiomicsRobustness (computer science):Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Diagnostic Techniques and Procedures::Diagnostic Techniques Radioisotope::Radionuclide Imaging::Tomography Emission-Computed::Positron-Emission Tomography [Medical Subject Headings]Resamplingradiomics feature robustness; imaging quantification; [11C]-methionine positron emission tomography; PET/MRI co-registration Appl.medicineGeneral Materials ScienceBiology (General)QD1-999InstrumentationSettore ING-INF/05 - Sistemi Di Elaborazione Delle InformazioniFluid Flow and Transfer Processesmedicine.diagnostic_testbusiness.industryTPhysicsProcess Chemistry and TechnologyRadiomics feature robustnessGeneral EngineeringPET/MRI co-registrationMagnetic resonance imagingPattern recognitionEngineering (General). Civil engineering (General)Imaging quantificationComputer Science ApplicationsChemistry:Chemicals and Drugs::Amino Acids Peptides and Proteins::Amino Acids::Amino Acids Essential::Methionine [Medical Subject Headings]Positron emission tomography[11C]-methionine positron emission tomography:Analytical Diagnostic and Therapeutic Techniques and Equipment::Diagnosis::Prognosis [Medical Subject Headings]Artificial intelligenceTA1-2040businessApplied Sciences
researchProduct

Metabolic Response Assessment in Non-Small Cell Lung Cancer Patients after Platinum-Based Therapy: A Preliminary Analysis

2015

The purpose of this study was to evaluate the clinical value of PET (Positron Emission Tomography) for early prediction of tumor response to platinum-based therapy in patients with nonsmall cell lung cancer (NSCLC). The evaluation was carried out comparing the standard treatment response using RECIST (Response Evaluation Criteria in Solid Tumors) with metabolic treatment response according to European Organization for Research and Treatment of Cancer (EORTC) recommendations, PET Response Criteria in Solid Tumors (PERCIST), Total Lesion Glycolysis (TLG) and Metabolic Tumor Volume (MTV). Seventeen inoperable patients with stage IV NSCLC were enrolled between October 2011 and June 2013: PET st…

Oncologymedicine.medical_specialtybusiness.industryF-FDG PETmedicine.disease18 F-FDG PET EORTC Non-small cell lung cancer PERCIST RECIST Therapy MonitoringPreliminary analysisResponse assessmentEORTCNon-small cell lung cancerRECISTTherapy MonitoringInternal medicinemedicineF-18-FDG PETRadiology Nuclear Medicine and imagingTherapy monitoringRadiologyNon small cellLung cancerbusinessPERCIST
researchProduct

A New Preclinical Decision Support System Based on PET Radiomics: A Preliminary Study on the Evaluation of an Innovative 64Cu-Labeled Chelator in Mou…

2022

The 64Cu-labeled chelator was analyzed in vivo by positron emission tomography (PET) imaging to evaluate its biodistribution in a murine model at different acquisition times. For this purpose, nine 6-week-old female Balb/C nude strain mice underwent micro-PET imaging at three different time points after 64Cu-labeled chelator injection. Specifically, the mice were divided into group 1 (acquisition 1 h after [64Cu] chelator administration, n = 3 mice), group 2 (acquisition 4 h after [64Cu]chelator administration, n = 3 mice), and group 3 (acquisition 24 h after [64Cu] chelator administration, n = 3 mice). Successively, all PET studies were segmented by means of registration with a standard te…

Settore ING-INF/05 - Sistemi Di Elaborazione Delle Informazioni64radiomics; micro-PET/CT; mouse imaging; atlas; <sup>64</sup>Cu-labeled chelatorCu-labeled chelatormicro-PET/CTComputer Graphics and Computer-Aided Design64Cu-labeled chelatoratlaradiomicsRadiology Nuclear Medicine and imagingatlasmouse imagingComputer Vision and Pattern RecognitionElectrical and Electronic EngineeringRadiomic64; Cu-labeled chelator; atlas; micro-PET/CT; mouse imaging; radiomicsradiomics; micro-PET/CT; mouse imaging; atlas; 64Cu-labeled chelator J.Journal of Imaging; Volume 8; Issue 4; Pages: 92
researchProduct

68 ga-dotatoc pet/ct follow up after single or hypofractionated gamma knife icon radiosurgery for meningioma patients

2021

68Ga-DOTATOC represents a useful tool in tumor contouring for radiosurgery planning. We present a case series of patients affected by meningiomas on who we performed 68Ga-DOTATOC positron emission tomography (PET)/CT pre-operatively, a subgroup of which also underwent a post-operative 68Ga-DOTATOC PET/CT to evaluate the standardized uptake value (SUV) modification after Gamma Knife ICON treatment in single or hypofractionated fractions. Twenty patients were enrolled/included in this study: ten females and ten males. The median age was 52 years (range 33–80). The median tumor diameter was 3.68 cm (range 0.12–22.26 cm), and the median pre-radiotherapy maximum SUV value was 11 (range 2.3–92). …

medicine.medical_treatmentStandardized uptake valueGalliumGamma knifeRadiosurgeryRadiosurgeryArticlelcsh:RC321-57168ga dotatocMeningioma03 medical and health sciences<sup>68</sup>Ga-DOTATOC PET/CT0302 clinical medicinemedicinelcsh:Neurosciences. Biological psychiatry. NeuropsychiatryPET-CTContouringmedicine.diagnostic_testbusiness.industryGamma KnifeGeneral NeuroscienceFollow upmedicine.diseasePositron emission tomography030220 oncology & carcinogenesisNuclear medicinebusiness68Ga-DOTATOC PET/CTMeningiomaHypofractionated030217 neurology & neurosurgery
researchProduct

Analysis of Metabolic Parameters Coming from Basal and Interim PET in Hodgkin Lymphoma

2018

Objective: Positron Emission Tomography (PET) with F-18-Fluoro-deoxy-glucose (FDG) emerged as a prognostic tool to predict treatment outcome in Hodgkin Lymphoma (HL). Moreover, a FDG-PET adapted strategy is currently assessed in clinical trial to minimize the toxic effect while maintaining the efficacy of treatment in HL. Purpose was to analyze the quantitative parameters to support the prognostic role of FDG-PET today based on the semi-quantitative Deauville 5-point Scale (D5-PS). Methods: This retrospective study included 53 patients diagnosed with advanced-stage HL between 2009 and 2014, enrolled in the PET response-adapted clinical trial HD 0607. FDG-PET was performed at baseline (PET0)…

Pathologymedicine.medical_specialtyChemothrapy; FDG PET; Hodgkin lymphoma; Metabolic parameters; Metabolic tumor volume; Prognostic value; Radiology Nuclear Medicine and Imagingbusiness.industryHODGkin lymphomaMetabolic tumor volume02 engineering and technology021001 nanoscience & nanotechnologyInterim pet03 medical and health sciencesBasal (phylogenetics)0302 clinical medicineNuclear Medicine and ImagingFDG PETmedicineHodgkin lymphomaRadiology Nuclear Medicine and imaging030212 general & internal medicineMetabolic parametersRadiology0210 nano-technologyNuclear medicinebusinessPrognostic valueChemothrapyCurrent Medical Imaging Reviews
researchProduct